Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:B4V vs VRTX, REGN, ALNY: Buyback Yield % Comparison
For the Biotechnology subindustry, ArcticZymes Technologies ASA's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ArcticZymes Technologies ASA Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where ArcticZymes Technologies ASA's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ArcticZymes Technologies ASA (FRA:B4V) has a Buyback Yield % of 0.00 as of Jul. 17, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on ArcticZymes Technologies ASA and its competitors. According to the industry distribution chart, ArcticZymes Technologies ASA ranks #999999 out of 740 companies in the Biotechnology industry.
Is ArcticZymes Technologies ASA's Buyback Yield % too high?
ArcticZymes Technologies ASA's current Buyback Yield % is 0.00. Based on the distribution chart, ArcticZymes Technologies ASA ranks #999999 out of 740 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, ArcticZymes Technologies ASA has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does ArcticZymes Technologies ASA's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ArcticZymes Technologies ASA ranks #999999 out of 740 companies for Buyback Yield %. This places ArcticZymes Technologies ASA in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on ArcticZymes Technologies ASA and its competitors. ArcticZymes Technologies ASA's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ArcticZymes Technologies ASA stock overvalued right now?
ArcticZymes Technologies ASA (FRA:B4V) has a current Buyback Yield % of 0.00. The stock's GF Value™ is €2.16, compared to a current price of €1.65 — trading 23.6% below its estimated fair value. The current Buyback Yield % is 0.00. ArcticZymes Technologies ASA's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For ArcticZymes Technologies ASA (FRA:B4V), the current Buyback Yield % is 0.00 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ArcticZymes Technologies ASA (FRA:B4V) Overvalued in 2026?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued.
The current stock price of €1.65 is trading 23.6% below its estimated GF Value™ of €2.16.
Key valuation signals for FRA:B4V:
Buyback Yield %: 0.00
GF Value™: €2.16 vs. price of €1.65 (23.6% below fair value)
No single metric tells the full story. See the FRA:B4V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
77GF Score
Get the complete analysis for FRA:B4V
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:B4V has been successfully added to your 
